Cargando…
Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis—the PMEP trial: study protocol for a randomized controlled trial
BACKGROUND: The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) respiratory infection in cystic fibrosis (CF) has increased dramatically over the last decade, and is now affecting approximately 25% of patients. Epidemiologic evidence suggests that persistent infection with MRSA resu...
Autores principales: | Jennings, Mark T, Boyle, Michael P, Weaver, David, Callahan, Karen A, Dasenbrook, Elliott C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068380/ https://www.ncbi.nlm.nih.gov/pubmed/24925006 http://dx.doi.org/10.1186/1745-6215-15-223 |
Ejemplares similares
-
Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study
por: Dolce, Daniela, et al.
Publicado: (2019) -
Antibacterial Activity of Small Molecules Which Eradicate Methicillin-Resistant Staphylococcus aureus Persisters
por: Hamad, Mohamad, et al.
Publicado: (2022) -
Methicillin‐resistant Staphylococcus aureus in health‐care workers with cystic fibrosis in Sydney
por: Song, Yang, et al.
Publicado: (2018) -
Intermittent colonisation with Methicillin-Resistant Staphylococcal aureus can be eradicated from the Airways of Adults with Cystic Fibrosis
por: Ranzenbacher, Lucy, et al.
Publicado: (2019) -
Gas Plasma Pre-treatment Increases Antibiotic Sensitivity and Persister Eradication in Methicillin-Resistant Staphylococcus aureus
por: Guo, Li, et al.
Publicado: (2018)